[Complications after TACE in HCC].
S
S
Schneeweiß
M
M
Horger
D
D
Ketelsen
S D
SD
Ioanoviciu
D000792:Angiography; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001659:Biliary Tract / Q000098:blood supply; D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects*; D054893:Cone-Beam Computed Tomography; D004305:Dose-Response Relationship, Drug; D004617:Embolism / Q000139:chemically induced / Q000175:diagnosis; D005704:Gallbladder / Q000098:blood supply; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D007238:Infarction / Q000139:chemically induced / Q000175:diagnosis; D007511:Ischemia / Q000139:chemically induced / Q000175:diagnosis; D008099:Liver / Q000098:blood supply; D008113:Liver Neoplasms / Q000098:blood supply / Q000628:therapy*; D013154:Spleen / Q000098:blood supply; D013577:Syndrome
D000970:Antineoplastic Agents